FDA Investigator Victoria Spivak
Victoria Spivak has inspections in 1 countries as of 25 Aug 2023. Victoria Spivak has collaborated with a combined 1234 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
25 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Alberto A Viciedo,
Amatul H Marium,
Amy L Singer,
Annemarie B Randow,
Annemarie Bodnar,
Anthony J Donato,
Atul J Agrawal,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Byungja E Marciante,
Cassandra L Abellard,
Daniel J Grabicki,
Deborah B Nixon,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Emest F Bizjak,
Emmanuel J Ramos,
Frederick Razzaghi,
Guerlain Ulysse,
Helen Verdel,
James M Mason,
James R Birkenstamm,
Janet A Rajan,
Jogy George,
Jonathan S Helfgott,
Jonee J Mearns,
Jose M Cayuela,
Jot R Klena,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen E D'orazio,
Karishma G Gopaul,
Keith M Reilly,
Kristy A Zielny,
Lata C Mathew, PhD,
Lauren L Vajo,
Liatte Kreuger, PharmD,
Loretta Nemchik,
Maria Estrella,
Melba Trivera Clavell,
Melissa T Roy,
Meyer J Slobotsky,
Michael R Klapal,
Michael Serrano,
Mindy M Chou,
Monika Borkowska,
Nancy F Scheraga,
Nerizza B Guerin,
Nicholas A Violand,
Niketa Patel,
Patrick C Klotzbuecher,
Paul L Bellamy,
Peter R Lenahan,
Pushpa S Jayasekara,
Rachael A Moliver,
Regina T Brown,
Robin P Mathew,
Rose Ljean Mary,
Russell J Glapion,
Samir C Gala,
Satheesh K Podaralla,
Stephen J Mottola,
Tara G Bizjak,
Tara R Gooen,
Unnee Ranjan,
Valerie C Reed,
Valerie Reed,
Yvins Dezan
Victoria Spivak's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2022 | FDA 483 | Advanced Accelerator Applications USA, Inc. - Form 483, 2022-11-03 |
November, 2022 | EIR | Advanced Accelerator Applications USA, Inc. - EIR, 2022-11-03 |
March, 2023 | FDA 483 | Maimonides Medical Center - Pharmacy - Form 483, 2023-03-09 |
November, 2022 | FDA 483 Response | Advanced Accelerator Applications USA, Inc. - Form 483R, 2022-11-03 |
August, 2023 | FDA 483 | SGS North America Inc. - Form 483, 2023-08-01 |
September, 2022 | EIR | Pfizer Inc - EIR, 2022-09-28 |
January, 2024 | FDA 483 | Radienz Living,LLC - Form 483, 2024-01-11 |
February, 2024 | FDA 483 | L'OREAL USA PRODUCTS, INC. - Form 483, 2024-02-15 |
April, 2024 | FDA 483 | Applechem, Inc. - Form 483, 2024-04-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more